We are live on ! Find out more
CAM

Cypress Asset Management Portfolio holdings

AUM $455M
1-Year Est. Return 26.87%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+26.87%
3 Year Est. Return
+113.59%
5 Year Est. Return
+132.49%
10 Year Est. Return
+426.19%
AUM
$522M
AUM Growth
+$19.8M
Cap. Flow
+$9.71M
Cap. Flow %
1.86%
Top 10 Hldgs %
24.77%
Holding
221
New
18
Increased
63
Reduced
99
Closed
10

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$3.78M
2
NEE icon
NextEra Energy
NEE
+$2.45M
3
WELL icon
Welltower
WELL
+$2.2M
4
YUM icon
Yum! Brands
YUM
+$1.45M
5
SNY icon
Sanofi
SNY
+$942K

Sector Composition

Rank Sector Weight
1 Consumer Staples 17.16%
2 Energy 14.65%
3 Industrials 13.91%
4 Healthcare 13.54%
5 Financials 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIS icon
26
Walt Disney
DIS
$168B
$5.85M 1.12%
56,139
-320
-0.6% -$31.2K
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.07T
$5.7M 1.09%
34,974
-100
-0.3% -$15.4K
GD icon
28
General Dynamics
GD
$105B
$5.42M 1.04%
31,367
+1,080
+4% +$177K
PNC icon
29
PNC Financial Services
PNC
$99.6B
$5.33M 1.02%
45,607
+2,010
+5% +$209K
OXY icon
30
Occidental Petroleum
OXY
$54.6B
$5.29M 1.01%
74,306
+3,112
+4% +$221K
IBB icon
31
iShares Biotechnology ETF
IBB
$9.44B
$5.11M 0.98%
+57,780
New +$5.26M
UNP icon
32
Union Pacific
UNP
$178B
$4.99M 0.96%
48,105
-1,745
-4% -$172K
INTC icon
33
Intel
INTC
$462B
$4.96M 0.95%
136,701
+8,088
+6% +$290K
OKE icon
34
Oneok
OKE
$56.4B
$4.71M 0.9%
82,020
+2,220
+3% +$116K
REGN icon
35
Regeneron Pharmaceuticals
REGN
$69.9B
$4.66M 0.89%
12,694
+89
+0.7% +$33.8K
GS icon
36
Goldman Sachs
GS
$309B
$4.58M 0.88%
+19,150
New +$3.89M
BMY icon
37
Bristol-Myers Squibb
BMY
$128B
$4.54M 0.87%
77,737
+2,938
+4% +$161K
STZ icon
38
Constellation Brands
STZ
$22.2B
$4.45M 0.85%
29,025
+985
+4% +$156K
CBRL icon
39
Cracker Barrel
CBRL
$1.17B
$4.4M 0.84%
26,334
+724
+3% +$109K
YUM icon
40
Yum! Brands
YUM
$40.7B
$4.12M 0.79%
65,025
-23,117
-26% -$1.45M
QQQ icon
41
Invesco QQQ Trust
QQQ
$449B
$4.04M 0.77%
34,115
-925
-3% -$109K
TWX
42
DELISTED
Time Warner Inc
TWX
$3.73M 0.71%
38,585
-415
-1% -$36.9K
ADI icon
43
Analog Devices
ADI
$181B
$3.58M 0.69%
49,292
-1,285
-3% -$87.4K
QCOM icon
44
Qualcomm
QCOM
$179B
$3.57M 0.68%
54,780
-85
-0.2% -$5.71K
DD
45
DELISTED
Du Pont De Nemours E I
DD
$3.51M 0.67%
47,874
-122
-0.3% -$8.66K
WBA
46
DELISTED
Walgreens Boots Alliance
WBA
$3.43M 0.66%
41,452
-205
-0.5% -$17K
PM icon
47
Philip Morris
PM
$305B
$3.39M 0.65%
37,005
-300
-0.8% -$27.8K
T icon
48
AT&T
T
$167B
$3.35M 0.64%
104,330
+16,569
+19% +$489K
CL icon
49
Colgate-Palmolive
CL
$73.6B
$3.16M 0.61%
48,259
-575
-1% -$39.4K
MDLZ icon
50
Mondelez International
MDLZ
$77.9B
$3.01M 0.58%
67,966
-2,799
-4% -$121K

Similar funds

Cypress Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Cypress Asset Management held 221 positions worth $522M, up 4% from $502M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Cypress Asset Management's Q4 2016 filing shows 18 new, 63 increased, 99 reduced and 10 closed positions. Its largest new stake was iShares Biotechnology ETF: 57,780 shares worth $5.11M. The largest sale was Ventas, an estimated $3.78M.

By sector, the portfolio is most concentrated in Consumer Staples at 17% of assets, down from 19% a quarter earlier, followed by Energy and Industrials.

  • Cypress Asset Management's largest Q4 2016 buy was iShares Biotechnology ETF: 57,780 shares worth $5.11M.
  • Cypress Asset Management added most to Verizon in Q4 2016, an estimated $1.11M increase.
  • Cypress Asset Management's biggest Q4 2016 reduction was NextEra Energy, cutting an estimated $2.45M.
  • Cypress Asset Management fully exited Ventas in Q4 2016, selling an estimated $3.78M.
  • Cypress Asset Management's ten largest holdings make up 25% of its $522M portfolio in Q4 2016.
  • Cypress Asset Management opened 18 new positions and closed 10 in Q4 2016.
  • Cypress Asset Management's portfolio value rose 4% quarter-over-quarter to $522M.

Based on Cypress Asset Management's 13F filing for Q4 2016, filed 7 Feb 2017.